Supreme Cannabis - Stock (TSX: FIRE) (OTCQX: SPRWF) - Investor Dashboard

Supreme Cannabis
TSX Ticker: FIRE
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees: >750 as of September 2019
Established: 2014
CEO: Nav Dhaliwal


Fiscal Year-End: June
Facilities: 4
Dried Flower: Production and Sale
Extracts:  Yes
Auditor: MNP
Headquarters: Toronto, ON

Financials (06/30/19)

Cash on hand: $54.8mm
Fixed Investment: $181.7mm
Shareholders’ Equity: $211.0mm
Revenues – Last Quarter: $19.0mm
Adj. Gross Margin : 54.2%
EPS : -0.00

Capital Structure (09/17/19)

Last Financing: $100mm Converts at 2.45
Basic Shares: 354.0 million
Warrants: 40.9 million
Options: 26.8 million
Diluted Shares: 465.3 million

Company Brief

The Supreme Cannabis Company Inc. ’s (“Supreme Cannabis”) first investment and now wholly owned operating subsidiary in the cannabis sector is the Canadian licensed producer 7ACRES, one of the first 40 federally legal licensed producers in Canada. 7ACRES is the only licensed producer focused on cultivating premium quality cannabis flower at commercial scale, its one-of-a-kind hybrid greenhouse is proudly rooted in Kincardine, Ontario.

Inside the 440,000-square foot facility, 7ACRES grows consistently high-quality plants by combining the best practices in indoor cannabis cultivation with the power of the sun. The result is indoor-quality buds with sun-grown characteristics. 7ACRES is the largest facility of its kind to grow with advanced HVAC and C02 enrichment using the full-spectrum sun, rather than the limited-spectrum lamps used by many ‘hybrid’ growers. This advantage has allowed Supreme to emerge as leaders in growing a premium quality cannabis flower at commercial scale.

Featured Video

Supreme Cannabis (TSX: FIRE) CEO Navdeep Dhaliwal speaks to BNN Bloomberg about how the company is growing in the cannabis industry.

Through the acquistion of wellness brand and extraction company Blissco, Supreme also has a production facility in Langley, British Columbia. The facility is expectd to ramp up to a 7 million-tincture bottle annual production capacity by the end of 2019. The company also has a facility in Toronto, Ontario through the acquistion of Truverra


  • Operates as a retail and B2B brand
  • Hybrid greenhouse facility ramping to 50,000 kilograms of production capacity
  • Extraction capabilities through Blissco’s production facility built to EU GMP standards
  • California-style production planned from indoor grow at Lot 16
  • Coast-to-coast distribution in Canada
  • Wholly owned subsidiary Cambium Plant Sciences focuses on cultivation IP and plant genetics
  • Truverra serves as the company’s global medical brand

Growth Strategy

  • Continued expansion at hybrid greenhouse facility in Kincardine
  • Development of indoor cultivation at Lot 16 to produce 10 million grams annually
  • International expansion
  • Addition of oil production capabilities
  • $10 million investment in and international distribution partnership with Medigrow Lesotho
  • International partnership with Khalifa Kush Enterprises
  • Entrance in the wellness area and in-house extraction capabilities through the acquisition of Blissco
  • Acquisition of Truverra gives the company brand, sales, and distribution in Europe
  • Supreme Heights will give Supreme Cannabis shareholders’ additional exposure to EU CBD markets
  • Plans for cannabis production in Malta


  • High-end focus with 7ACRES branded premium dried flower
  • Scalable expansion within hybrid greenhouse
  • Supply agreements with eight Canadian provinces: Ontario, British Columbia, Alberta, Manitoba, Nova Scotia, Prince Edward Island, New Brunswick, and Saskatchewan
  • C$12 million supply agreement with Tilray
  • $6 million supply agreement with Cannmart
  • Brand partnerships with PAX and KKE

Institutional Analyst Coverage

Matthew Bottomley
Canaccord Genuity

Jesse Pytlak
Cormark Securities

Jason Zandberg
PI Financial

Robert Fagan
GMP Securities

Graeme Kreindler
Eight Capital

The 7ACRES Team

Curated Stories & News

Visit Supreme Cannabis

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Supreme Pharmaceuticals, Inc. is a client of NCV Media, LLC. Read our full disclaimer.